Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP15 Revolutionizing Treatment: Fenbendazole and Ivermectin's New Frontiers"
Fenben® Voices
6 minutes
10 months ago
S1EP15 Revolutionizing Treatment: Fenbendazole and Ivermectin's New Frontiers"
Got Questions? Send us a message!Tune into "Fenben Voices" for "Revolutionizing Treatment: Fenbendazole and Ivermectin's New Frontiers." This episode discusses the repurposing of fenbendazole and ivermectin from veterinary use to promising cancer treatments. Dive into the narrative as we cover:Potential of Fenbendazole and Ivermectin: Examining their mechanisms against cancer.Legal and Ethical Landscape: The complexities of using experimental drugs in human medicine.Patient Access and Right-t...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
